MedTrace Logo

The Human Microbiome and IVF Outcomes

NCT03637777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2023-05-03

No results posted yet for this study

Summary

Patients and partners undergoing an autologous IVF cycle will be recruited to participate in this prospective observational study investigating the microbiome and its association with IVF pregnancy outcomes. During the the controlled ovarian hyperstimulation cycle as well as the frozen embryo transfer cycle, a number of specimens will be collected for next generation sequencing of 16S rRNA to evaluate the microbiome profile of the reproductive and gastrointestinal tracts. Data on pregnancy outcomes will be collected prospectively and evaluated to identify associations with the microbiome.

Conditions

Interventions

DIAGNOSTIC_TEST

16S rRNA gene sequencing

Specimens collected from patients will be used for next generation sequencing of the bacteria-specific 16S rRNA gene

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Jason Franasiak, MD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2022-10-11
Completion
2022-12-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03637777 on ClinicalTrials.gov